Minnesota HF3922 mandates fair pricing in community pharmacy reimbursement to support financial viability and patient access.
Minnesota HF3922 requires pharmacy benefit managers (PBMs) and managed care organizations (MCOs) to reimburse community pharmacies at or above the National Average Drug Acquisition Cost (NADAC) or Wholesale Acquisition Cost (WAC) for prescription drugs. It prohibits below-cost reimbursements and negative reimbursement adjustments, ensuring community pharmacies receive fair compensation. The bill also mandates a professional dispensing fee, adjusted biennially based on an independent cost-of-dispensing survey to reflect inflation, labor costs, and operational expenses.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.